Cara Therapeutics Q3 2023 results reveal lower revenue and focus on oral difelikefalin pipeline By Investing.com
© Reuters. Cara Therapeutics Inc. (NASDAQ:) recently disclosed its third-quarter financial results for 2023, revealing a drop in total revenue ...
